MTVA
MetaVia Inc.

14,717
Mkt Cap
$16.89M
Volume
1.44M
52W High
$30.25
52W Low
$6.05
PE Ratio
-5.39
MTVA Fundamentals
Price
$14.10
Prev Close
$7.32
Open
$7.70
50D MA
$9.86
Beta
1.00
Avg. Volume
336,890.87
EPS (Annual)
-$3.56
P/B
27.98
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
IMG, MTVA, USREF, TGL: These Four Stocks Trade Ex-Reverse Split On Friday
A reverse split raises the stock’s price by reducing the share count, helping the company regain compliance and avoid delisting.
Stocktwits·1d ago
News Placeholder
More News
News Placeholder
MetaVia Inc. Announces 1-for-11 Reverse Stock Split
MetaVia Inc. Announces 1-for-11 Reverse Stock Split MetaVia Inc. Announces 1-for-11 Reverse Stock Split PR Newswire CAMBRIDGE, Mass., Dec. 2, 2025 CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire...
PR Newswire·3d ago
News Placeholder
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting 2025
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting 2025 MetaVia Presents Positive New Phase 2a Data on Vanoglipel...
PR Newswire·28d ago
News Placeholder
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire CAMBRIDGE, Mass...
PR Newswire·29d ago
News Placeholder
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025 MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek 2025 PR Newswire CAMBRIDGE, Mass...
PR Newswire·1mo ago
News Placeholder
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting PR Newswire...
PR Newswire·1mo ago
News Placeholder
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference PR Newswire CAMBRIDGE, Mass., Oct. 14, 2025...
PR Newswire·2mo ago
News Placeholder
MetaVia to Present at Upcoming Investor and Industry Conferences
MetaVia to Present at Upcoming Investor and Industry Conferences MetaVia to Present at Upcoming Investor and Industry Conferences PR Newswire CAMBRIDGE, Mass., Aug. 26, 2025 CAMBRIDGE, Mass., Aug...
PR Newswire·3mo ago
News Placeholder
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference PR Newswire CAMBRIDGE...
PR Newswire·11mo ago
News Placeholder
MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH
MetaVia to Participate in the 9th Annual MASH-TAG 2025 Conference After Releasing Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH MetaVia to...
PR Newswire·1y ago

Latest MTVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.